CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
bupivacaine 100 mg +1 moredrug
Likely dose
bupivacaine 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03249662
NCT03249662N/ACompleted

Efficacy of Pain Management in Different Concentrations of Bupivacaine in Periarticular Injection and Plasma Concentrations of Bupivacaine in Patients Undergoing Bilateral Knee Arthroplasty

Mahidol University·interventional·Posted Aug 15, 2017·Updated Sep 16, 2020

In Brief

A clinical study evaluating bupivacaine 200 mg and bupivacaine 100 mg for Bilateral Total Knee Arthroplasty. Completed, enrolled 60 participants across 1 site.

Detailed Summary

To study efficacy of postoperative pain control of different concentrations of bupivacaine for periarticular infiltration, part of multimodal analgesia, in bilateral total knee arthroplasty. To study plasma concentration of bupivacaine in patient who received spinal anesthesia and single shot bilateral adductor canal block and periarticular infiltration with bupivacaine for safety level.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesThailand
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 15, 2017
Enrollment StartSep 27, 2017
Primary CompletionSep 14, 2020
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 8.9 years ago

Interventions

bupivacaine 200 mgprocedure

bupivacaine 200 mg ketorolac 30 mg epinephrine 400 mcg add NSS to 80 ml divided to two syringes for bilateral periarticular infiltration

bupivacaine 100 mgdrug

bupivacaine 100 mg ketorolac 30 mg epinephrine 400 mcg add NSS to 80 ml divided to two syringes for bilateral periarticular infiltration